Marinus Pharmaceuticals reported 2.49M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 63.48M 1.86M
Amgen AMGN:US $ 5077M 182M
Biogen BIIB:US $ 2021.4M 59.7M
Eisai 4523:JP Y 207950M 6650M
Enanta Pharmaceuticals ENTA:US $ 47.46M 8.94M
Esperion Therapeutics ESPR:US 25.12M 2.18M
Gilead Sciences GILD:US $ 3787M 706M
Intercept Pharmaceuticals ICPT:US $ 46.14M 1.47M
Intra Cellular Therapies ITCI:US $ 32.83M 12.68M
Marinus Pharmaceuticals MRNS:US 2.49M 697K
Ptc Therapeutics PTCT:US $ 141.29M 30.83M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Sarepta Therapeutics SRPT:US $ 197.2M 25.56M
Supernus Pharmaceuticals SUPN:US $ 145.15M 3.78M
Vertex Pharmaceuticals VRTX:US $ 1292.8M 156M
YTE INCY:US $ 562.34M 53.96M